ICON plc/$ICLR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About ICON plc

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Ticker

$ICLR
Primary listing

Industry

Life Sciences Tools & Services

Headquarters

Dublin, Ireland

Employees

41,250

ISIN

IE0005711209

ICON plc Metrics

BasicAdvanced
$12B
16.16
$9.19
1.24
-

What the Analysts think about ICON plc

Analyst ratings (Buy, Hold, Sell) for ICON plc stock.

Bulls say / Bears say

Barclays maintains an 'Overweight' rating on ICON plc with a price target of $275, citing the company's strong profitability and potential for future mergers and acquisitions. (Investing.com)
BetterInvesting Magazine highlights ICON plc as potentially undervalued, suggesting investment opportunities for growth-oriented investors. (GuruFocus)
Despite recent stock price declines, ICON plc maintains strong fundamentals with a P/E ratio of 14.5 and healthy profit margins of 29.5%, indicating potential resilience and undervaluation. (Investing.com)
ICON plc faces a securities fraud class action lawsuit alleging misrepresentations about business deterioration due to customer cost reductions and industry funding limitations. (GuruFocus)
The company reported a 4.3% decline in revenue to $2.00 billion for the quarter ended March 31, missing analyst expectations and indicating potential challenges in maintaining growth. (TradingView News)
ICON plc's stock has experienced a significant decline, reaching a 52-week low of $138.47, reflecting market challenges and investor concerns about future performance. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 7 Jun 2025.

ICON plc Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

ICON plc Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ICLR

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs